Jeremy David Purser, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2967 Oak Run Pkwy # 210, New Braunfels, TX 78132 Phone: 830-626-5551 Fax: 830-626-5593 |
Kristen Nicole Gathright, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1770 State Highway 46 W, New Braunfels, TX 78132 Phone: 830-730-4125 Fax: 830-312-7896 |
John Michael Tieman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1584 E Common St, New Braunfels, TX 78130 Phone: 800-337-6663 Fax: 830-608-0470 |
Dr. Vicente Quintero, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2967 Oak Run Pkwy Ste 210, New Braunfels, TX 78132 Phone: 830-626-5551 Fax: 830-626-5593 |
Dr. Stephen George Stahr, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2154 Gabriels Pl Ste 103, New Braunfels, TX 78130 Phone: 833-353-2875 Fax: 833-518-3378 |
Alfred J Hockley Iii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2154 Gabriels Pl Ste 103, New Braunfels, TX 78130 Phone: 833-353-2875 Fax: 833-518-3378 |
John Henry Anderson, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 901 Loop 337 # A, New Braunfels, TX 78130 Phone: 830-625-1786 Fax: 830-606-7546 |
Dr. Liliana J. Saap, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 790 Generations Dr, Ste 200, New Braunfels, TX 78130 Phone: 830-214-7060 Fax: 830-500-3180 |
Danielle Brown, MD Dermatology - Pediatric Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2967 Oak Run Pkwy Ste 210, New Braunfels, TX 78132 Phone: 830-626-5551 Fax: 830-626-5593 |
Walter C. Anderson Iii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 901a Loop 337, New Braunfels, TX 78130 Phone: 830-625-1786 |
News Archive
QHR Technologies Inc., a leader in the Canadian Healthcare Information Technology sector, is pleased to announce today the release of its annual audited financial statements for the year ended December 31, 2010.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.
"A new Cochrane Systematic Review examines the accuracy of Rapid Diagnostic Tests (RDTs), which are designed to detect malaria based on the presence of parasite antigens, using a quick and easy to use format," according to a press release issued by Wiley.
Pregnant women have been warned not to use scented creams or perfumes during the first three months of their pregnancy because they may jeopardise the future fertility of unborn boys.
Data from a longitudinal study of over 500,000 people in the United Kingdom indicate that having higher levels of the personality trait neuroticism may reduce the risk of death for individuals who report being in fair or poor health.
› Verified 6 days ago